D.A. Davidson & Co’s iShares US Pharmaceuticals ETF IHE Stock Holding History

D.A. Davidson & Co’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.63M	Sell	18,816 -1,332	-7%	-$117K	0.01%	761
2025 Q4	$1.71M	Buy	+20,148	New	+$1.61M	0.01%	719
2019 Q1	–	Sell	-7,875	Closed	-$370K	–	1151
2018 Q4	$370K	Buy	7,875 +975	+14%	+$50K	0.01%	742
2018 Q3	$386K	Buy	+6,900	New	+$377K	0.01%	809
2017 Q3	–	Sell	-114	Closed	-$5K	–	1519
2017 Q2	$5K	Hold	114	–	–	﹤0.01%	2199
2017 Q1	$5K	Buy	+114	New	+$5.64K	﹤0.01%	2169
2015 Q2	–	Sell	-27,144	Closed	-$1.56M	–	2242
2015 Q1	$1.56M	Sell	27,144 -1,887	-6%	-$103K	0.05%	313
2014 Q4	$1.47M	Sell	29,031 -1,083	-4%	-$52.8K	0.05%	331
2014 Q3	$1.41M	Sell	30,114 -213	-0.7%	-$9.61K	0.05%	338
2014 Q2	$1.36M	Buy	30,327 +9	+0%	+$387	0.05%	351
2014 Q1	$1.28M	Sell	30,318 -3,483	-10%	-$146K	0.05%	344
2013 Q4	$1.33M	Sell	33,801 -1,233	-4%	-$46.3K	0.05%	321
2013 Q3	$1.24M	Sell	35,034 -684	-2%	-$24.1K	0.06%	307
2013 Q2	$1.19M	Buy	+35,718	New	+$1.19M	0.06%	289

Other funds holding IHE

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

FIA

Foundations Investment Advisors Phoenix, Arizona $8.07B AUM 24.97% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ACA

Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return

MSCM

McElhenny Sheffield Capital Management Dallas, Texas $403M AUM 28.73% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

ACM

Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

D.A. Davidson & Co's IHE Position: Q1 2026 in Review

D.A. Davidson & Co reduced its iShares US Pharmaceuticals ETF (IHE) stake by 6.6% in Q1 2026, selling an estimated $117K and leaving 18,816 shares worth $1.63M. The position accounts for 0.01% of the portfolio, ranked #761.

D.A. Davidson & Co first reported a position in IHE in Q2 2013 and has held it in 14 quarters since. The position peaked at $1.71M in Q4 2025. 194 funds tracked by Wall St. Rank hold IHE as of Q1 2026.

D.A. Davidson & Co held 18,816 shares of iShares US Pharmaceuticals ETF worth $1.63M as of Q1 2026.
D.A. Davidson & Co sold 1,332 iShares US Pharmaceuticals ETF shares in Q1 2026, an estimated $117K.
iShares US Pharmaceuticals ETF made up 0.01% of D.A. Davidson & Co's portfolio in Q1 2026, its #761 holding.
D.A. Davidson & Co first reported a position in iShares US Pharmaceuticals ETF in Q2 2013 and has held it in 14 quarters since.
D.A. Davidson & Co's iShares US Pharmaceuticals ETF position peaked at $1.71M in Q4 2025.
194 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2026.

Based on D.A. Davidson & Co's 13F filing for Q1 2026, filed 5 May 2026.